Cat.#: ACPP-1334
| Despition | DRP1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1138 | Recombinant Human Semaphorin 7a Protein (6×His Tag) (AC1138) | 50 µg | inquiry |
| ACPP-1803 | Human KISS1 Protein (AC1803) | 2 µg | inquiry |
| ACPP-1242 | MC3 Receptor Blocking Peptide (AC1242) | 250 µg | inquiry |
| ACPP-1562 | Human TAGLN3 Protein (AC1562) | 5 µg | inquiry |
| ACPP-1313 | Norepinephrine Transporter Blocking Peptide (AC1313) | 250 µg | inquiry |
| ACPP-1456 | Human HEXA Protein (AC1456) | 5 µg | inquiry |
| ACPP-1685 | Human MOG Protein (AC1685) | 10 µg | inquiry |
| ACPP-1452 | Human HSD17B1 Protein (AC1452) | 2 µg | inquiry |
| ACPP-1434 | Human CD34 Protein, GST (AC1434) | 2 µg | inquiry |
| ACPP-1187 | 5HT1A Blocking Peptide (AC1187) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.